- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06566664
Peripheral Neurostimulation
Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.
By studying this subject, the investigators open possibilities for improvement on many levels:
increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.
The results of this study will open the door to novel approaches to manage acute post-operative pain.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
California
-
Stanford, California, Estados Unidos, 94305
- Stanford University Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Undergoing elective upper limb surgery with a planned brachial plexus nerve block
Exclusion Criteria:
- Under 18 years old
- ASA score above III
- Chronic pain condition with daily milligrams of morphine equivalent > 30
- Poorly controlled psychiatric condition
- Coagulopathy
- Active infection
- Moderate, severe or progressing neuropathy
- COPD/Chronic oxygen user
- Pregnancy
- Incarceration
- Unable to consent
- BMI > 35
- Pacemaker
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Ultrasound-guided brachial plexus block with peripheral nerve stimulation
Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch. |
Nerve stimulator that is traditionally used for nerve localization during block placements. |
|
Comparador Falso: Ultrasound-guided brachial plexus block without peripheral nerve stimulation
Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient. |
Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Onset of Motor Block
Prazo: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve) |
Within 1 hour after the block placement.
|
|
Onset of Sensory Block
Prazo: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder. |
Within 1 hour after the block placement.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Skin Temperature Change
Prazo: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor. |
Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
|
When Patient Experiences First Pain
Prazo: up to day 7 post operatively
|
Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history. |
up to day 7 post operatively
|
|
Time of First Opioid Taken
Prazo: Within the first 7 days after surgery
|
As measured by asking patients if they were taking opioids daily after surgery, up to one week. |
Within the first 7 days after surgery
|
|
Total Post Operative MME/Opioid Usage at Day 1
Prazo: On Post Operative Day 1
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 1
|
|
Total Post Operative MME/Opioid Usage at Day 2
Prazo: On Post Operative Day 2
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 2
|
|
Total Post Operative MME Opioid Usage at Day 3
Prazo: On Post Operative Day 3
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 3
|
|
Total Post Operative MME Opioid Usage at Day 4
Prazo: On Post Operative Day 4
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 4
|
|
Total Post Operative MME Opioid Usage at Day 5
Prazo: On Post Operative Day 5
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 5
|
|
Total Post Operative MME Opioid Usage at Day 6
Prazo: On Post Operative Day 6
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 6
|
|
Opioid Usage Assessment at Day 7
Prazo: On Post Operative Day 7
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 7
|
|
Opioid Usage Assessment at Day 28
Prazo: On Post Operative Day 28
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day. |
On Post Operative Day 28
|
|
Opioid Usage Assessment at 6 Months
Prazo: On Post Operative Month 6
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day. |
On Post Operative Month 6
|
|
Opioid Usage Assessment at 1 Year
Prazo: On Post Operative 1 Year
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day. |
On Post Operative 1 Year
|
|
Quality of Recovery
Prazo: At Post Operative days 7 and 28 , 6 months, and 1 year
|
Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best. PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed |
At Post Operative days 7 and 28 , 6 months, and 1 year
|
|
General satisfaction
Prazo: At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N). |
At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
|
Adverse Events
Prazo: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness |
Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
|
Catheter Duration Before Discontinuation
Prazo: After surgery, up until catheter discontinuation.
|
Patients' catheter duration before discontinuation, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
|
Total Local Anesthetic Use with Catheter
Prazo: After surgery, up until catheter discontinuation.
|
Patients' local anesthetic use with catheter, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 76523
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .